Summaries
COVID-19 rapid guideline: dialysis service delivery
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
COVID-19 rapid guideline: chronic kidney disease
This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
NICE Acute kidney injury guideline
For information on assessing risk factors in adults having iodine-based contrast media or surgery, ongoing assessment of the condition of people in hospital, and preventing acute kidney injury in adults having iodine-based contrast media, see the full guideline.
NICE pyelonephritis (acute): antimicrobial prescribing
This summary provides a treatment algorithm for the appropriate prescribing of antimicrobials for acute pyelonephritis.
NICE anaemia in CKD guideline
This summary on the management of anaemia in people with chronic kidney disease features a treatment algorithm to help with clinical practice.
Educational resources
Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment
This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.